- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02459522
Bayesian Estimation of Diagnostic Performance for Cardiovascular Autonomic Neuropathy
September 20, 2016 updated by: Zihui Tang, Shanghai Tongji Hospital, Tongji University School of Medicine
Bayesian Estimation of Diagnostic Performance of Short-term Heart Rate Variability for Cardiovascular Autonomic Neuropathy Without a Gold Standard
This study aimed to evaluate the reference values for the short-term heart rate variable (HRV), estimate the performance of cardiovascular autonomic neuropathy (CAN) diagnostic tests in the absence of a gold standard, and assess CAN prevalence in our cross-sectional dataset.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The CAN prevalence is rapidly growing in all populations worldwide.
No document has been reported about normal reference values for CAN using this test in the Chinese population.
This study aimed to evaluate the reference values for the short-term HRV in a large cross-sectional dataset, and to estimate sensitivities and specificities of CAN diagnostic tests using the Bayesian approach, in the absence of a gold standard in another independence dataset.
Finally, CAN prevalence was estimated in the investigators' cross-sectional dataset.
Firstly, the reference the values for the short-term HRV were calculated in the investigators' previous study (including 371 healthy subjects).
This study dataset contained 88 subjects who completed both the short-term HRV test and Ewing's test.
Simultaneous inferences about the population prevalence and the performance of each diagnostic test were possible using the Bayesian approach without a gold standard.
Study Type
Observational
Enrollment (Actual)
88
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200065
- Shanghai Tongji Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Individuals with inclusion and exclusion criteria were recruited from healthy examination centres to assess cardiovascular autonomic function using both the short-term heart rate variability and Ewing's tests.
Description
Inclusion Criteria:
- Survey participants with undiagnosed CAN, aged 30-80 years, were included in this study.
Exclusion Criteria:
Some subjects were excluded from the study to eliminate potential confounding factors that may have influenced their CA function 11. Briefly, the exclusion criteria were as follows:
- history or findings of arrhythmia, and hyperthyroidism or hypothyroidism;
- pregnancy or lactation; and/or
- serious hepatic or renal dysfunctions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Dr.Tang's research group
This group included participants with completed both the short-term HRV test and Ewing's test.
|
This is a cross-sectional study for estimation of diagnostic performance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiovascular autonomic function evaluate by short-term heart rate variability test
Time Frame: participants will be measured for the duration of outpatient stay, an expected average of two days
|
Both short-term heart rate variability and Ewing's test measure cardiovascular autonomic function
|
participants will be measured for the duration of outpatient stay, an expected average of two days
|
Cardiovascular autonomic function evaluate by Ewing's test
Time Frame: participants will be measured for the duration of outpatient stay, an expected average of two days
|
Both short-term heart rate variability and Ewing's test measure cardiovascular autonomic function
|
participants will be measured for the duration of outpatient stay, an expected average of two days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Zihui Tang, M.D and Ph.D, Shanghai Tongji Hospital, Tongji University School of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Tang ZH, Zeng F, Yu X, Zhou L. Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on baroreflex sensitivity in the absence of a gold standard. Int J Cardiol. 2014 Feb 15;171(3):e78-80. doi: 10.1016/j.ijcard.2013.11.100. Epub 2013 Dec 6. No abstract available.
- Zeng F, Tang ZH, Li Z, Yu X, Zhou L. Normative reference of short-term heart rate variability and estimation of cardiovascular autonomic neuropathy prevalence in Chinese people. J Endocrinol Invest. 2014 Apr;37(4):385-91. doi: 10.1007/s40618-013-0047-4. Epub 2014 Jan 9.
- Tang ZH, Wang L, Zeng F, Li Z, Yu X, Zhang K, Zhou L. Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short-term heart rate variability without a gold standard. BMJ Open. 2014 Oct 6;4(9):e005096. doi: 10.1136/bmjopen-2014-005096.
- Tang ZH, Zeng F, Ye K, Yu X, Zhou L. The analysis of a reference value for baroreflex sensitivity and cardiovascular autonomic neuropathy prevalence in a Chinese population. Eur J Med Res. 2014 Feb 12;19(1):8. doi: 10.1186/2047-783X-19-8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
May 27, 2015
First Submitted That Met QC Criteria
May 28, 2015
First Posted (Estimate)
June 2, 2015
Study Record Updates
Last Update Posted (Estimate)
September 22, 2016
Last Update Submitted That Met QC Criteria
September 20, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CANHRVB_Dr.Tang
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diagnostic Performance of Cardiovascular Autonomic Neuropathy
-
Genlantis DiagnosticsNorthwestern UniversityNot yet recruitingTo Demonstrate Clinical Performance of the TriQuik Invitro Diagnostic Device
-
Shanghai Tongji Hospital, Tongji University School...Huashan HospitalCompleted
-
Shanghai Tongji Hospital, Tongji University School...Huashan HospitalCompletedCardiovascular Autonomic NeuropathyChina
-
University of Alabama at BirminghamCompletedAutonomic Dysfunction | Cardiovascular Autonomic Neuropathy | Diabetic Autonomic NeuropathyUnited States
-
Shanghai Tongji Hospital, Tongji University School...Huashan HospitalCompletedDiabetic Cardiovascular Autonomic NeuropathyChina
-
Shanghai Tongji Hospital, Tongji University School...CompletedDiabetic Cardiovascular Autonomic Neuropathy (DCAN)China
-
Chelsea TherapeuticsCompletedNeurogenic Orthostatic Hypotension | Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Non-Diabetic Neuropathy
-
Aalborg University HospitalCompleted
-
Chelsea TherapeuticsChiltern International Inc.CompletedA Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa (NOH301)Primary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension (NOH) | Non-diabetic NeuropathyUnited States, Canada
-
Chelsea TherapeuticsChiltern International Inc.CompletedPrimary Autonomic Failure | Dopamine Beta Hydroxylase Deficiency | Symptomatic Neurogenic Orthostatic Hypotension (NOH) | Non-diabetic NeuropathyUnited States, Australia, Canada, New Zealand
Clinical Trials on not intervention
-
University of ManchesterRecruitingDementia | Abuse Client | Neglect; Care, MalnutritionUnited Kingdom
-
Hospital Regional de Alta Especialidad del BajioRecruiting
-
Assistance Publique - Hôpitaux de ParisEuropean Association of Cardiovascular ImagingNot yet recruitingAortic Valve Stenosis | Aortic Valve Disease | Heart Valve Diseases | Mitral Valve Insufficiency | Aortic Valve Insufficiency | Mitral Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Tricuspid Valve Insufficiency | Mitral Valve Disease | Tricuspid Valve Disease | Mitral Valve Insufficiency and... and other conditionsFrance
-
Shanghai Tongji Hospital, Tongji University School...CompletedDiabetic Cardiovascular Autonomic Neuropathy (DCAN)China
-
Shanghai Tongji Hospital, Tongji University School...Huashan HospitalCompletedDiabetic Cardiovascular Autonomic NeuropathyChina
-
The Christie NHS Foundation TrustRecruitingHead and Neck Cancer | Anxiety | OncologyUnited Kingdom
-
Shanghai Tongji Hospital, Tongji University School...Huashan HospitalCompleted
-
Rashid Centre for Diabetes and ResearchCompletedDietary HabitsUnited Arab Emirates
-
Shanghai Tongji Hospital, Tongji University School...Huashan HospitalCompletedCardiovascular Autonomic NeuropathyChina
-
Johns Hopkins UniversityTruth InitiativeCompleted